242 related articles for article (PubMed ID: 31754744)
21. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
He C; Wang H; Liao WD; Peng C; Shu X; Zhu X; Zhu ZH
World J Gastroenterol; 2019 May; 25(18):2204-2216. PubMed ID: 31143071
[TBL] [Abstract][Full Text] [Related]
22. Gut microbial composition difference between pediatric ALL survivors and siblings.
Thomas R; Wong WSW; Saadon R; Vilboux T; Deeken J; Niederhuber J; Hourigan SK; Yang E
Pediatr Hematol Oncol; 2020 Sep; 37(6):475-488. PubMed ID: 32427521
[TBL] [Abstract][Full Text] [Related]
23. Antibiotics in early life: dysbiosis and the damage done.
Neuman H; Forsythe P; Uzan A; Avni O; Koren O
FEMS Microbiol Rev; 2018 Jul; 42(4):489-499. PubMed ID: 29945240
[TBL] [Abstract][Full Text] [Related]
24. From the Cover: Exposure to Oral Antibiotics Induces Gut Microbiota Dysbiosis Associated with Lipid Metabolism Dysfunction and Low-Grade Inflammation in Mice.
Jin Y; Wu Y; Zeng Z; Jin C; Wu S; Wang Y; Fu Z
Toxicol Sci; 2016 Nov; 154(1):140-152. PubMed ID: 27503388
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota dysbiosis is associated with Henoch-Schönlein Purpura in children.
Wang X; Zhang L; Wang Y; Liu X; Zhang H; Liu Y; Shen N; Yang J; Gai Z
Int Immunopharmacol; 2018 May; 58():1-8. PubMed ID: 29525681
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiome in children with enthesitis-related arthritis in a developing country and the effect of probiotic administration.
Aggarwal A; Sarangi AN; Gaur P; Shukla A; Aggarwal R
Clin Exp Immunol; 2017 Mar; 187(3):480-489. PubMed ID: 27861762
[TBL] [Abstract][Full Text] [Related]
27. Antibiotic and Modulation of Microbiota: A New Paradigm?
Rizzatti G; Ianiro G; Gasbarrini A
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
29. Association of metformin administration with gut microbiome dysbiosis in healthy volunteers.
Elbere I; Kalnina I; Silamikelis I; Konrade I; Zaharenko L; Sekace K; Radovica-Spalvina I; Fridmanis D; Gudra D; Pirags V; Klovins J
PLoS One; 2018; 13(9):e0204317. PubMed ID: 30261008
[TBL] [Abstract][Full Text] [Related]
30. Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice.
Le Bastard Q; Ward T; Sidiropoulos D; Hillmann BM; Chun CL; Sadowsky MJ; Knights D; Montassier E
Sci Rep; 2018 Apr; 8(1):6219. PubMed ID: 29670191
[TBL] [Abstract][Full Text] [Related]
31. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
33. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
34. Autophagy Genes of Host Responds to Disruption of Gut Microbial Community by Antibiotics.
Singh SB; Wilson M; Ritz N; Lin HC
Dig Dis Sci; 2017 Jun; 62(6):1486-1497. PubMed ID: 28466260
[TBL] [Abstract][Full Text] [Related]
35. Effects of Panax ginseng polysaccharides on the gut microbiota in mice with antibiotic-associated diarrhea.
Li S; Qi Y; Chen L; Qu D; Li Z; Gao K; Chen J; Sun Y
Int J Biol Macromol; 2019 Mar; 124():931-937. PubMed ID: 30503788
[TBL] [Abstract][Full Text] [Related]
36. Tributyltin exposure induces gut microbiome dysbiosis with increased body weight gain and dyslipidemia in mice.
Guo H; Yan H; Cheng D; Wei X; Kou R; Si J
Environ Toxicol Pharmacol; 2018 Jun; 60():202-208. PubMed ID: 29738946
[TBL] [Abstract][Full Text] [Related]
37. Antibiotics, pediatric dysbiosis, and disease.
Vangay P; Ward T; Gerber JS; Knights D
Cell Host Microbe; 2015 May; 17(5):553-64. PubMed ID: 25974298
[TBL] [Abstract][Full Text] [Related]
38. Gut Microbial Dysbiosis in Indian Children with Autism Spectrum Disorders.
Pulikkan J; Maji A; Dhakan DB; Saxena R; Mohan B; Anto MM; Agarwal N; Grace T; Sharma VK
Microb Ecol; 2018 Nov; 76(4):1102-1114. PubMed ID: 29564487
[TBL] [Abstract][Full Text] [Related]
39. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
Breban M; Tap J; Leboime A; Said-Nahal R; Langella P; Chiocchia G; Furet JP; Sokol H
Ann Rheum Dis; 2017 Sep; 76(9):1614-1622. PubMed ID: 28606969
[TBL] [Abstract][Full Text] [Related]
40. Characterization of oral and gut microbiome temporal variability in hospitalized cancer patients.
Galloway-Peña JR; Smith DP; Sahasrabhojane P; Wadsworth WD; Fellman BM; Ajami NJ; Shpall EJ; Daver N; Guindani M; Petrosino JF; Kontoyiannis DP; Shelburne SA
Genome Med; 2017 Feb; 9(1):21. PubMed ID: 28245856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
